The US Food and Drug Administration (FDA) has granted clearance for Canada-based developer of neurosurgery products Synaptive Medical's BrightMatter Guide system for use in operating rooms.
BrightMatter Guide will now be used in hospitals and surgical facilities for their clinical workflow.
The new neuro-navigation system shows 3D tractographic visuals of the brain in the operating room to help surgeons in guiding their tools and informing their surgical approach.
The company said the 3D DTI visuals, carefully overlaid on an anatomical scan, offer valuable information allowing surgeons to visualise the brain's internal networks.
In addition, the new system offers continuous tracking of multiple tools throughout a procedure for real-time location updates within the surgical cavity.
Synaptive Medical president Cameron Piron said: "BrightMatter Guide is a GPS of sorts for the brain, giving surgeons a visual representation of the complex structures and associated tractography of the brain in the operating room, where they need them.
"Combined with our other technologies, Synaptive can streamline the entire procedure, from pre-operative imaging to post-operative evaluation.
"We are providing surgeons with the tools to adapt to the changing surgical environment, integrating imaging modalities and technologies as they are needed. I am looking forward to seeing Guide successfully used in operating rooms around the country."
A new solution called Servo will be formed in the operating room, when BrightMatter Guide is interfaced with the company's BrightMatter Vision and BrightMatter Drive technologies.
Servo mounts an effective optics platform, including Guide, Vision and Drive, onto an automated positioning system for use with BrightMatter Guide.
The BrightMatter Servo solution allows a surgeon to automatically track surgical tools with Drive and replace cumbersome optics with Vision, as well as evaluate a surgical plan in the operating room with Guide.